Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 91601-91650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05155189
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
PHASE1
Recruiting
44 participants
Started: Dec 9, 2021 · Completed: May 31, 2041
1 condition
1 sponsor
2 locations
NCT06322290
Epidemiological Study on Invasive Bacterial Diseases
N/A
Recruiting
5,000 participants
Started: Dec 9, 2021 · Completed: Mar 30, 2032
1 condition
1 sponsor
38 locations
NCT05197270
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
PHASE1/PHASE2
Recruiting
215 participants
Started: Dec 9, 2021 · Completed: Jan 31, 2031
1 condition
1 sponsor
24 locations
NCT05171478
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
N/A
Recruiting
20 participants
Started: Dec 9, 2021 · Completed: Dec 8, 2025
2 conditions
1 sponsor
1 location
NCT05169970
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
PHASE2
Recruiting
215 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT05183906
Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious Keratitis
N/A
Recruiting
100 participants
Started: Dec 9, 2021 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT04499131
Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters
PHASE4
Recruiting
108 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04969471
NATURE (EnVast As an Adjunct PPCI in Subjects Presenting with STEMI)
NA
Recruiting
148 participants
Started: Dec 9, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04702256
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
PHASE3
Recruiting
196 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2031
2 conditions
2 sponsors
1 location
NCT04866329
Female Fertility, Environmental Agents and Stress Oxidant
N/A
Recruiting
500 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05274230
Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy
NA
Recruiting
200 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04934475
MInimal Residual Disease Adapted Strategy
PHASE3
Active, not recruiting
791 participants
Started: Dec 8, 2021 · Completed: Sep 30, 2028
1 condition
4 sponsors
73 locations
NCT04667663
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
PHASE1
Active, not recruiting
16 participants
Started: Dec 8, 2021 · Completed: Apr 30, 2026
1 condition
3 sponsors
3 locations
NCT05000645
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
NA
Recruiting
570 participants
Started: Dec 8, 2021 · Completed: Oct 31, 2027
2 conditions
2 sponsors
1 location
NCT04982367
Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
NA
Recruiting
166 participants
Started: Dec 8, 2021 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT04150198
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NA
Recruiting
45 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2026
2 conditions
2 sponsors
2 locations
NCT05417802
Surveying Patient's Interest in Robotic Rehabilitation Device
N/A
Active, not recruiting
88 participants
Started: Dec 8, 2021 · Completed: Dec 7, 2026
1 condition
1 sponsor
1 location
NCT04786028
A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM
PHASE2
Active, not recruiting
72 participants
Started: Dec 8, 2021 · Completed: Jun 30, 2027
1 condition
1 sponsor
7 locations
NCT05005897
Early Infant Micronutrition and Development
PHASE2/PHASE3
Recruiting
600 participants
Started: Dec 8, 2021 · Completed: Oct 15, 2029
1 condition
4 sponsors
1 location
NCT05127941
Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE)
N/A
Active, not recruiting
141 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2025
1 condition
1 sponsor
2 locations
NCT04774913
Invest-CTO PCI Trial
NA
Recruiting
200 participants
Started: Dec 8, 2021 · Completed: Oct 31, 2026
4 conditions
2 sponsors
5 locations
NCT05216432
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1
Recruiting
930 participants
Started: Dec 8, 2021 · Completed: Apr 30, 2027
7 conditions
1 sponsor
37 locations
NCT04733950
Cochlear Implanted Listening Effort and Hearing Attention
NA
Recruiting
170 participants
Started: Dec 8, 2021 · Completed: Feb 22, 2026
1 condition
1 sponsor
1 location
NCT04587791
Cannabidiol in Opioid Use Disorder and Chronic Pain
EARLY_PHASE1
Recruiting
40 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2026
2 conditions
3 sponsors
1 location
NCT04867681
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
NA
Active, not recruiting
40 participants
Started: Dec 8, 2021 · Completed: Apr 24, 2026
1 condition
1 sponsor
1 location
NCT06290505
A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
PHASE2
Recruiting
54 participants
Started: Dec 8, 2021 · Completed: Jul 31, 2029
1 condition
1 sponsor
9 locations
NCT05053854
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
PHASE1
Recruiting
24 participants
Started: Dec 8, 2021 · Completed: Jun 30, 2029
1 condition
1 sponsor
1 location
NCT04987957
Effect Of Musıc Therapy On Anxıety Levels In COVID-19 Pandemıc
NA
Recruiting
42 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04377932
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
PHASE1
Active, not recruiting
24 participants
Started: Dec 8, 2021 · Completed: Aug 26, 2040
6 conditions
2 sponsors
1 location
NCT05164107
Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
NA
Recruiting
175 participants
Started: Dec 8, 2021 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05028972
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
NA
Recruiting
1,050 participants
Started: Dec 8, 2021 · Completed: Sep 30, 2026
3 conditions
2 sponsors
6 locations
NCT05155605
PATHFINDER 2: a Multi-Cancer Early Detection Study
NA
Active, not recruiting
35,885 participants
Started: Dec 8, 2021 · Completed: Apr 30, 2028
2 conditions
1 sponsor
56 locations
NCT04984967
Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology
NA
Recruiting
116 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2025
3 conditions
1 sponsor
1 location
NCT04389281
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
PHASE1
Recruiting
20 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
4 locations
NCT06286878
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
PHASE2/PHASE3
Recruiting
80 participants
Started: Dec 8, 2021 · Completed: Jul 30, 2025
4 conditions
1 sponsor
1 location
NCT05751018
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
PHASE2
Recruiting
45 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06995313
Biofeedback Training for Hemianopia
NA
Recruiting
70 participants
Started: Dec 8, 2021 · Completed: Jul 8, 2026
2 conditions
1 sponsor
1 location
NCT04817254
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PHASE2
Active, not recruiting
47 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05122754
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
PHASE4
Active, not recruiting
150 participants
Started: Dec 8, 2021 · Completed: Apr 28, 2024
1 condition
3 sponsors
3 locations
NCT04151472
Idebenone for the Preventive Treatment of Migraine
PHASE3
Recruiting
180 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05173597
Real-world Evidence on Follitropin Delta Individual Dosing
N/A
Recruiting
850 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT05003895
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)
PHASE1
Recruiting
38 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT05081479
A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma
PHASE1
Active, not recruiting
9 participants
Started: Dec 8, 2021 · Completed: Oct 21, 2025
1 condition
1 sponsor
7 locations
NCT05099276
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
PHASE4
Active, not recruiting
46 participants
Started: Dec 7, 2021 · Completed: Jun 1, 2024
3 conditions
1 sponsor
1 location
NCT04717674
[18F]FPIA PET/CT Imaging in Patients With Solid Tumours
PHASE2
Recruiting
21 participants
Started: Dec 7, 2021 · Completed: Oct 31, 2024
2 conditions
4 sponsors
3 locations
NCT05181475
Long-term Efficacy and Safety Study of GV-971
PHASE4
Active, not recruiting
800 participants
Started: Dec 7, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
40 locations
NCT06412211
A Clinical Feasibility Study of a Photoacoustic Finder
N/A
Active, not recruiting
129 participants
Started: Dec 7, 2021 · Completed: Sep 30, 2024
2 conditions
2 sponsors
1 location
NCT06490237
Coding of Speech Signals in the Human Auditory Nerve
NA
Recruiting
60 participants
Started: Dec 7, 2021 · Completed: Jun 7, 2027
1 condition
1 sponsor
1 location
NCT05002777
Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)
PHASE2
Active, not recruiting
22 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2029
1 condition
1 sponsor
27 locations
NCT04702581
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
PHASE3
Recruiting
280 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2030
3 conditions
1 sponsor
26 locations
Previous
1
More pages
1830
1831
1832
1833
1834
1835
1836
More pages
2369
Next